A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)

Authors :: Mark W. Frohlich
Nancy L. Bartlett
John G. Gribben
Ronald J. Berenson
Joe Stephenson
Ralph V. Boccia
V. M. Mizuno
Michael Milder
Charles H. Redfern
Source :: Biology of Blood and Marrow Transplantation. (2):76
Publisher :: American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.

Subjects :: Oncology
medicine.medical_specialty
Transplantation
Refractory
business.industry
Internal medicine
medicine
Phases of clinical research
In patient
Hematology
medicine.disease
business
Non-Hodgkin's lymphoma

Full Text Access

Tools